Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Open accessThe DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.
Abstract
Inflammatory bowel diseases, which include Crohn’s disease and ulcerative colitis, affect several million individuals worldwide. Crohn’s disease and ulcerative colitis are complex diseases that are heterogeneous at the clinical, immunological, molecular, genetic, and microbial levels. Individual contributing factors have been the focus of extensive research. As part of the Integrative Human Microbiome Project (HMP2 or iHMP), we followed 132 subjects for one year each to generate integrated longitudinal molecular profiles of host and microbial activity during disease (up to 24 time points each; in total 2,965 stool, biopsy, and blood specimens). Here we present the results, which provide a comprehensive view of functional dysbiosis in the gut microbiome during inflammatory bowel disease activity. We demonstrate a characteristic increase in facultative anaerobes at the expense of obligate anaerobes, as well as molecular disruptions in microbial transcription (for example, among clostridia), metabolite pools (acylcarnitines, bile acids, and short-chain fatty acids), and levels of antibodies in host serum. Periods of disease activity were also marked by increases in temporal variability, with characteristic taxonomic, functional, and biochemical shifts. Finally, integrative analysis identified microbial, biochemical, and host factors central to this dysregulation. The study’s infrastructure resources, results, and data, which are available through the Inflammatory Bowel Disease Multi’omics Database ( http://ibdmdb.org ), provide the most comprehensive description to date of host and microbial activities in inflammatory bowel diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This relative absence of biomarkers for active UC may result both from its generally more benign phenotype (IBDMDB Investigators et al., 2019) and from the smaller number of active UC samples (n = 23) compared with active CD samples (n = 76); as a result, we focused our subsequent analyses on expression differences within the CD subcohort.”
From Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3 (2021) · cites this paper as IBDMDB Investigators et al., 2019
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This network of mechanistic associations identified several key components that are central to the alterations seen in IBD, highlighting octanoyl carnitine, several lipids and short-chain fatty acids, the taxa Faecalibacterium, Subdoligranulum, Roseburia, Alistipes, and Escherichia, some at both the metagenomic and metatranscriptomic levels, and host regulators of interleukins49.”
From The Integrative Human Microbiome Project (2019) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Multiple lines of evidence point towards central roles of gut microbiome perturbations in the pathogenesis of IBD.”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [152]
The cited source says what the claim attributes to it.
In the citing paper
“These studies, which have now reached the first stage of completion49–51, together provide a wealth of information and insights about not only microbial dynamics, but also associated human host responses and microbial inter-relationships.”
From The Integrative Human Microbiome Project (2019) · cites this paper as [49]
In the citing paper
“The authors could then use the 17 top taxa in their ranked list to identify which individuals are dysbiotic, an approach that demonstrated similar or better performance than the GMWI2 or another published metric called the “dysbiotic score”.195”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [195]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
Wickham, H. (2016) · Use R! · doi:10.1007/978-3-319-24277-4 · Cited by 33,115
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,826
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
Self-citationUPARSE: highly accurate OTU sequences from microbial amplicon reads
Edgar, R. C. (2013) · Nature Methods · doi:10.1038/nmeth.2604 · Cited by 16,707
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
Fast and sensitive protein alignment using DIAMOND
Buchfink, B., Xie, C., & Huson, D. H. (2015) · Nature Methods · doi:10.1038/nmeth.3176 · Cited by 14,201
Cited by
Items 701–800 of 1,010
Thuy-Boun, P. S., Wang, A. Y., Crissien-Martinez, A., Xu, J. H., Chatterjee, S., Stupp, G. S., Su, A. I., Coyle, W., & Wolan, D. W. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100197 · Cited by 48
Van den Abbeele, P., Deyaert, S., Albers, R., Baudot, A., & Mercenier, A. (2023) · Nutrients · doi:10.3390/nu15092090 · Cited by 46
Microbial and genetic-based framework identifies drug targets in inflammatory bowel disease
Wang, Z., Guo, K., Gao, P., Pu, Q., Lin, P., Qin, S., Xie, N., Hur, J., Li, C. L., Huang, C., et al. (2021) · Theranostics · doi:10.7150/thno.59196 · Cited by 43
“We observed a clearer separation between ileum with colon or rectum samples (Figure S1A), consistent with the previous analysis that tissue location was a driver of intestinal gene expression [10].”
BackgroundMethodResultInfluentialLong-term dynamics of the human oral microbiome during clinical disease progression
Duran-Pinedo, A. E., Solbiati, J., Teles, F., Teles, R. P., Zang, Y., & Frias‐Lopez, J. (2021) · BMC Biology · doi:10.1186/s12915-021-01169-z · Cited by 50
Zhu, Y., Xu, Y., Wang, X., Rao, L., Yan, X., Gao, R., Shen, T., Zhou, Y., Kong, C., & Zhou, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.886061 · Cited by 50
“Emerging evidence suggests that gut microbiota dysbiosis contributes to the pathogenesis of IBD; for instance, opportunistic pathogen derived from ulcerative colitis patients displayed an inflammatory phenotype that caused mice colitis (Lloyd-Price et al., 2019; Seishima et al., 2019).”
BackgroundSpondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies
Cozzi, G., Scagnellato, L., Lorenzin, M., Savarino, E. V., Zingone, F., Ometto, F., Favero, M., Doria, A., Vavricka, S. R., & Ramonda, R. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-00984-8 · Cited by 47
The vitamin B5/coenzyme A axis: A target for immunomodulation?
MIALLOT, R., Millet, V., Galland, F., & Naquet, P. (2023) · European Journal of Immunology · doi:10.1002/eji.202350435 · Cited by 50
Liu, Y., Duan, H., Chen, Y., Zhang, C., Zhao, J., Narbad, A., Tian, F., Zhai, Q., Yu, L., & Chen, W. (2023) · iMeta · doi:10.1002/imt2.136 · Cited by 48
“The etiology and pathophysiology of IBD are unknown, however, it is widely postulated that a complex interplay involving the host genome, environmental factors, gut microbiota, intestinal barrier, and immune response contributes to its onset [8 – 10].”
BackgroundDissecting mechanisms of fecal microbiota transplantation efficacy in disease
Andary, C. M., Al, K. F., Chmiel, J. A., Gibbons, S., Daisley, B. A., Parvathy, S. N., Vareki, S. M., Bowdish, D. M. E., Silverman, M., & Burton, J. P. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.12.005 · Cited by 48
Jiang, S., Xiao, G., Koh, A. Y., Kim, J., Li, Q., & Zhan, X. (2019) · Biostatistics · doi:10.1093/biostatistics/kxz050 · Cited by 46
Zou, D., Pei, J., Lan, J., Sang, H., Chen, H., Yuan, H., Wu, D., Zhang, Y., Wang, Y., Wang, D., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102652 · Cited by 47
Microbiome-Based Biomarkers for IBD
Ananthakrishnan, A. N. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa071 · Cited by 45
Self-citationKelly, R. S., Mendez, K. M., Huang, M., Hobbs, B. D., Clish, C. B., Gerszten, R. E., Cho, M. H., Wheelock, C. E., McGeachie, M. J., Chu, S. H., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202105-1268oc · Cited by 49
Self-citationTierney, B. T., Tan, Y., Yang, Z., Shui, B., Walker, M. J., Kent, B. M., Kostic, A. D., & Patel, C. J. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001556 · Cited by 46
Role of metabolites derived from gut microbiota in inflammatory bowel disease
Zheng, L., Wen, X., & Duan, S.-L. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i9.2660 · Cited by 45
Roth‐Schulze, A. J., Penno, M. A. S., Ngui, K., Oakey, H., Bandala‐Sanchez, E., Smith, A. D., Allnutt, T. R., Thomson, R. L., Vuillermin, P., Craig, M. E., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01104-y · Cited by 44
Strain Identification and Quantitative Analysis in Microbial Communities
Ghazi, A. R., Münch, P. C., Chen, D., Jensen, J., & Huttenhower, C. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167582 · Cited by 46
Self-citationKubinski, R., Djamen-Kepaou, J.-Y., Zhanabaev, T., Hernández-García, Á., Bauer, S., Hildebrand, F., Korcsmáros, T., Karam, S., Jantchou, P., Kafi, K., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.784397 · Cited by 44
Zuo, W., Michail, S. K., & Sun, F. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.918010 · Cited by 45
Xie, X., Li, Q., Jia, L., Yuan, H., Guo, T., & Meng, T. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202954 · Cited by 42
Wan, S., Wang, K., Huang, P., Guo, X., Liu, W., Li, Y., Zhang, J., Li, Z., Song, J., Yang, W., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47710-w · Cited by 47
Preto, A. J., Chanana, S., Ence, D., Healy, M. D., Domingo‐Fernándéz, D., & West, K. (2025) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae197 · Cited by 53
“Notable examples include the 1000IBD project, which has collected genomics, gut microbiome taxonomic profiles, and fecal metagenomics from over 1,000 patients (Imhann et al. , 2019), and the IBD Database, featuring a wide range of omics data from more than 100 patients (Lloyd-Price et al. , 2019).”
BackgroundLiang, S., Zhao, D., Liu, X., Liu, B., & Li, Y. (2025) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2025.103503 · Cited by 46
MetaLab 2.0 Enables Accurate Post-Translational Modifications Profiling in Metaproteomics
Cheng, K., Ning, Z., Zhang, X., Li, L., Liao, B., Mayne, J., & Figeys, D. (2020) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.0c00083 · Cited by 38
Luminal microbiota related to Crohn’s disease recurrence after surgery
Hamilton, A. L., Kamm, M. A., Cruz, P. P. D., Wright, E. K., Feng, H., Wagner, J., Sung, J. J. �., Kirkwood, C. D., Inouye, M., & Teo, S. M. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1778262 · Cited by 46
Kellermayer, R., & Zilbauer, M. (2020) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002908 · Cited by 40
“6% of samples in UC were dysbiotic, and that ‘‘dysbiosis is triggered in part by stochastic (ie, random, the authors) events’’ (84).”
BackgroundAlcohol use alters the colonic mucosa–associated gut microbiota in humans
Gurwara, S., Dai, A., Ajami, N. J., Graham, D. Y., White, D. L., Chen, L., Jang, A., Chen, E., El‐Serag, H. B., Petrosino, J. F., et al. (2020) · Nutrition Research · doi:10.1016/j.nutres.2020.09.004 · Cited by 44
“Subdoligranulum is similarly reduced in inflammatory bowel disease [46].”
BackgroundSelf-citationBacteriotherapy for inflammatory bowel disease
Yoshimatsu, Y., Mikami, Y., & Kanai∥, T. (2021) · Inflammation and Regeneration · doi:10.1186/s41232-020-00153-4 · Cited by 44
Detection of cell-free microbial DNA using a contaminant-controlled analysis framework
Zozaya‐Valdés, E., Wong, S. Q., Raleigh, J., Hatzimihalis, A., Ftouni, S., Papenfuss, A. T., Sandhu, S. K., Dawson, M. A., & Dawson, S. (2021) · Genome biology · doi:10.1186/s13059-021-02401-3 · Cited by 45
“across DEBs A/B and DEBs F/G), a previously published function called PERMANOVA_repeated_measures which is a modified version of adonis that implements a repeated measurement aware PERMANOVA (RMA-PERMANOVA) was used [47].”
MethodFucosyltransferase 2: A Genetic Risk Factor for Intestinal Diseases
Hu, M., Zhang, X., Li, J., Chen, L., He, X., & Sui, T. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.940196 · Cited by 52
“Roseburia hominis amount↑ Produce acylcarnitines (Lloyd-Price et al., 2019)”
InfluentialOral‐gut bacterial profiles discriminate between periodontal health and diseases
Lourenço, T. G. B., de Oliveira, A. M., Chen, T., & Colombo, A. P. V. (2022) · Journal of Periodontal Research · doi:10.1111/jre.13059 · Cited by 66
Radhakrishnan, S. T., Gallagher, K., Mullish, B. H., Serrano-Contreras, J. I., Alexander, J. L., Blanco, J. M., Danckert, N. P., Valdivia‐Garcia, M., Hopkins, B. J., Ghai, A., et al. (2023) · Scientific Reports · doi:10.1038/s41598-022-27131-9 · Cited by 46
Progress and challenges in exploring aquatic microbial communities using non-targeted metabolomics
Thukral, M., Allen, A. E., & Petras, D. (2023) · The ISME Journal · doi:10.1038/s41396-023-01532-8 · Cited by 47
Methodological Considerations in Longitudinal Analyses of Microbiome Data: A Comprehensive Review
Lyu, R., Qu, Y., Divaris, K., & Wu, D. (2023) · Genes · doi:10.3390/genes15010051 · Cited by 50
“For example, the longitudinal microbiome data collected from the adult Inflammatory bowel disease (IBD) has followed 132 subjects for one year during disease (up to 24 time points each) [2].”
BackgroundInfluentialThe role of intestinal microbiota and metabolites in intestinal inflammation
Ma, W., Huang, Z., Liu, K., Li, D., Mo, T., & Liu, Q. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127838 · Cited by 47
Bae, M., Le, C., Mehta, R. S., Dong, X., Pieper, L. M., Ramirez, L., Alexander, M., Kiamehr, S., Turnbaugh, P. J., Huttenhower, C., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.10.002 · Cited by 43
Self-citationIntegrating multi-omics data to reveal the host-microbiota interactome in inflammatory bowel disease
Su, F., Su, M., Wei, W., Wu, J., Chen, L., Sun, X., Liu, M., Sun, S., Mao, R., Bourgonje, A. R., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2476570 · Cited by 44
“112,113 This suggests that host-microbiota interactions are not static, which poses a challenge to host-microbiota interactome studies.”
Fang, Z., Yang, X., & Shang, L. (2025) · Science Advances · doi:10.1126/sciadv.adt2131 · Cited by 45
“Increasing evidence suggests that UC development is closely associated with changes in gut microbiota, such as reduced microbial diversity, a decline in beneficial bacteria, and functional disruptions ( 22 ).”
From microbiome to metabolism: Bridging a two-decade translational gap
Hul, M. V., & Cani, P. D. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.10.011 · Cited by 57
Ryan, F. J., Drew, D. P., Douglas, C. A., Leong, L. E. X., Moldovan, M. V., Lynn, M. A., Fink, N. H., Sribnaia, A., Penttila, I., McPhee, A. J., et al. (2019) · mSystems · doi:10.1128/msystems.00484-19 · Cited by 46
“Spearman correlation analysis was used to identify associations between the relative abundances of CAGs of ESVs in the microbiota at 1, 2, and 3 months of life and normalized blood gene expression levels at BPD diagnosis in an approach similar to that previously described by the Human Microbiome Project in reference 4…”
MethodAn Introduction to Whole-Metagenome Shotgun Sequencing Studies
Joseph, T., & Pe’er, I. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1103-6_6 · Cited by 46
Fuentes‐Chust, C., Parolo, C., Rosati, G., Rivas, L., Perez‐Toralla, K., Simon, S., de Lecuona, I., Junot, C., Trebicka, J., & Merkoçi, A. (2021) · Advanced Materials · doi:10.1002/adma.202006104 · Cited by 47
Gao, L., Yu, Q., Zhang, H., Wang, Z., Zhang, T., Xiang, J., Yu, S., Zhang, S., Wu, H., Xu, Y., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb5071 · Cited by 49
Jagt, J. Z., Struys, E. A., Ayada, I., Bakkali, A., Jansen, E. E. W., Claesen, J., Limbergen, J. V., Benninga, M. A., de Boer, N. K. H., & de Meij, T. G. J. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab256 · Cited by 43
The Role of Gastrointestinal Microbiota in Functional Dyspepsia: A Review
Zhou, L., Zeng, Y., Zhang, H., & Ma, Y. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.910568 · Cited by 46
“…progression of many human diseases are more or less related to the dysbiosis of the gastrointestinal microbiota, such as inflammatory bowel disease (Lloyd-Price et al., 2019), FD (Tziatzios et al., 2020), irritable bowel syndrome (Shin et al., 2019) and other gastrointestinal diseases,…”
BackgroundZhang, B., Yang, L., Ning, H., Cao, M., Chen, Z., Chen, Q., Lian, G., Tang, H., Wang, Q., Wang, J., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02159-21 · Cited by 40
Ashniev, G. A., Petrov, S. N., Iablokov, S. N., & Rodionov, D. A. (2022) · Microorganisms · doi:10.3390/microorganisms10040740 · Cited by 47
“We analyzed whole genome shotgun sequencing (WGS) metagenomic samples from the Integrative Human Microbiome Project (iHMP) on functional dysbiosis in the gut microbiome during Inflammatory Bowel Disease (IBD) activity [56].”
MethodTherapeutic interventions target the NLRP3 inflammasome in ulcerative colitis: Comprehensive study
Ali, F. E. M., Ibrahim, I. M., Ghogar, O. M., Abd‐alhameed, E. K., Althagafy, H. S., & Hassanein, E. H. M. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i6.1026 · Cited by 42
Gut microbiome as a therapeutic target for liver diseases
Singh, T. P., Kadyan, S., Devi, H., Park, G., & Nagpal, R. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121685 · Cited by 44
Gut Microbiota Composition in Long-Remission Ulcerative Colitis is Close to a Healthy Gut Microbiota
Guise, C. H.-D., Varela, E., Sarrabayrouse, G., Pozuelo, M., Alonso, V. R., Borruel, N., Casellas, F., Mayorga, L., Manichanh, C., Azpiroz, F., et al. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad058 · Cited by 41
Gao, Y., & Tian, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411811 · Cited by 43
Metagenomic estimation of dietary intake from human stool
Diener, C., Holscher, H. D., Filek, K., Corbin, K. D., Moissl-Eichinger, C., & Gibbons, S. M. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01220-1 · Cited by 38
Jalanka, J., Cheng, J., Hiippala, K., Ritari, J., Salojärvi, J., Ruuska, T. H., Kalliomäki, M. A., & Satokari, R. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176044 · Cited by 50
Chen, Y., Lei, J., & He, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.692160 · Cited by 45
“Gene-Expression Omnibus data sets with clinical information and available data (GSE111889, Supplementary Table 1; LloydPrice et al., 2019) were enrolled in our study.”
MethodInfluentialRousta, E., Oka, A., Liu, B., Herzog, J., Bhatt, A. P., Wang, J., Najafi, M. B. H., & Sartor, R. B. (2021) · Nutrients · doi:10.3390/nu13103565 · Cited by 48
“Gammaproteobacteria are reproducibly increased in patients with active IBD [32,33], and AIEC induce cecal-predominant colitis in monoassociated gnotobiotic 129 SvEv IL10−/− [19].”
BackgroundRoles of Gut Bacteriophages in the Pathogenesis and Treatment of Inflammatory Bowel Disease
Qv, L., Mao, S., Li, Y., Zhang, J., & Li, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.755650 · Cited by 46
“Researches have reported the dysbiosis of gut bacteria both in CD and UC patients, with a decreased diversity, expanded potentially pathogenic proteobacteria (e.g., E. coli, Fusobacteria) and reduced potentially protective Firmicutes (e.g., Faecalibacterium prausnitzii, Rumininococci and Clostridium clusters IV and XI…”
BackgroundPrebiotic effects of goji berry in protection against inflammatory bowel disease
Sun, Q., Du, ., Kang, Y., & Zhu, M. J. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.2015680 · Cited by 42
Zhang, Y., Luo, H., Niu, Y., Yang, X., Li, Z., Wang, K., Bi, H.-J., & Pang, X. (2022) · Sleep Medicine · doi:10.1016/j.sleep.2022.02.003 · Cited by 44
Application of emerging technologies for gut microbiome research
Kwa, W. T., Sundarajoo, S., Toh, K. Y., & Lee, J. W. J. (2023) · Singapore Medical Journal · doi:10.4103/singaporemedj.smj-2021-432 · Cited by 43
“[29] Given their potential anti‑inflammatory effects, coupled with the reduction of SCFAs and their corresponding SCFA‑producing bacteria Singapore Medical Journal ¦ Volume 64 ¦ Issue 1 ¦ January 2023 49 in patients with IBD, SCFAs have been often considered a promising therapeutic option for the clinical management o…”
BackgroundInfluentialThe multifaceted virulence of adherent-invasive Escherichia coli
Mansour, S., Asrar, T., & Elhenawy, W. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2172669 · Cited by 45
“Therefore, it is not surprising that low endogenous concentrations of SCFAs have been associated with gut inflammation.(91) In line with their proinflammatory behavior, AIEC are more adept than commensal E.”
BackgroundLi, S., Qian, Q., Yang, H., Wu, Z., Xie, Y., Yin, Y., Cui, Y., & Li, X. (2023) · Nutrition Research · doi:10.1016/j.nutres.2023.11.009 · Cited by 41
Carbohydrate-based Prebiotics in Targeted Modulation of Gut Microbiome.
Lam, K.-L., & Cheung, P. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b04811 · Cited by 23
FsNet: Feature Selection Network on High-dimensional Biological Data
Singh, D., Climente-González, H., Petrovich, M., Kawakami, E., & Yamada, M. (2023) · International Joint Conference on Neural Networks (IJCNN) · doi:10.1109/ijcnn54540.2023.10191985 · Cited by 38
“We studied a metagenome dataset [29], which contains information regarding the gut bacteria of 359 healthy individuals and 958 patients with inflammatory bowel disease.”
MethodLochhead, P. J., Khalili, H., Sachs, M. C., Chan, A. T., Olén, O., & Ludvigsson, J. F. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa235 · Cited by 43
Self-citationPaediatric Inflammatory Bowel Disease and its Relationship with the Microbiome
Fitzgerald, R. S., Sanderson, I. R., & Claesson, M. J. (2021) · Microbial Ecology · doi:10.1007/s00248-021-01697-9 · Cited by 42
Stem Cell Impairment at the Host-Microbiota Interface in Colorectal Cancer
Marzano, M., Fosso, B., Piancone, E., Defazio, G., Pesole, G., & Robertis, M. D. (2021) · Cancers · doi:10.3390/cancers13050996 · Cited by 41
“[193] where ten different data types (e.”
Barnett, M. P. G., Young, W., Armstrong, K., Brewster, D. T., Cooney, J. M., Ellett, S., Espley, R. V., Laing, W. A., Maclean, P. H., McGhie, T. K., et al. (2021) · Nutrients · doi:10.3390/nu13041092 · Cited by 39
“a possible therapy for some forms of these diseases [23].”
BackgroundAmos, G. C. A., Sergaki, C., Logan, A., Iriarte, R., Bannaga, A., Chandrapalan, S., Wellington, E. M. H., Rijpkema, S. G. T., & Arasaradnam, R. P. (2021) · Scientific Reports · doi:10.1038/s41598-021-96942-z · Cited by 47
Feng, X., Du, C., & Wang, C. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.09.175 · Cited by 43
Fecal Microbiome Composition Does Not Predict Diet‐Induced TMAO Production in Healthy Adults
Ferrell, M., Bazeley, P. S., Wang, Z., Levison, B. S., Li, X. S., Jia, X., Krauss, R. M., Knight, R. D., Lusis, A. J., García-García, J. C., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021934 · Cited by 41
Self-citationYang, F., Ni, B., Liu, Q., He, F., Li, L., Zhong, X., Zheng, X., Lu, J., Chen, X., Lin, H., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03118-1 · Cited by 40
“[17] provided a comprehensive view of functional dysbiosis in the gut microbiome during IBD activity.”
BackgroundGut Microbiota in Nutrition and Health with a Special Focus on Specific Bacterial Clusters
Bresser, L. R. F., de Goffau, M. C., Levin, E., & Nieuwdorp, M. (2022) · Cells · doi:10.3390/cells11193091 · Cited by 44
Toward a health-associated core keystone index for the human gut microbiome
Goel, A., Shete, O., Goswami, S., Samal, A., C.B., L., Kedia, S., Ahuja, V., O’Toole, P. W., Shanahan, F., & Ghosh, T. S. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115378 · Cited by 37
Schut, G. J., Thorgersen, M. P., Poole, F. L., Haja, D. K., Putumbaka, S., & Adams, M. W. W. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2109008118 · Cited by 41
“To estimate the prevalence of WOR and W transporters at a transcript and protein level in gut microbes, we analyzed a comprehensive metatransciptomics dataset of 735 gut microbiome samples (indexed with enzyme commission (EC) numbers) and an analogous proteomics dataset of 450 samples (33).”
BackgroundMethodActive Multiple-Sampling Capsule for Gut Microbiome
Park, S., Lee, H., Kim, D., Kee, H., & Park, S. (2022) · IEEE/ASME Transactions on Mechatronics · doi:10.1109/tmech.2022.3155534 · Cited by 39
Machine Learning Based Microbiome Signature to Predict Inflammatory Bowel Disease Subtypes
Liñares-Blanco, J., Fernandez-Lozano, C., Seoane, J. A., & López–Campos, G. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.872671 · Cited by 42
“A substantial body of evidence supports a relevant role of the microbiota in inflammatory bowel disease (IBD) (Franzosa et al., 2019; Lloyd-Price et al., 2019; Amoroso et al., 2020; Ananthakrishnan, 2020; De Musis et al., 2020; Glassner et al., 2020; Haifer et al., 2020; Aldars-García et al., 2021),…”
BackgroundStool multi-omics for the study of host–microbe interactions in inflammatory bowel disease
Sauceda, C., Bayne, C. F., Sudqi, K., González, A., Dulai, P. S., Knight, R. D., Gonzalez, D. J., & Gonzalez, C. G. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2154092 · Cited by 41
“’s staggering effort collected longitudinal stool-basedomics data (in addition to other non-stool-basedomics) from a large cohort of IBD patients.(68) Deep integration of these data yielded an association network with over 51,000 connections, a large subset of which were highly significant.”
BackgroundSelf-citationLeung, M. H. Y., Tong, X., Shen, Z., Du, S., Bastien, P., Appenzeller, B. M. R., Betts, R. J., Mezzache, S., Bourokba, N., Cavusoglu, N., et al. (2023) · Microbiome · doi:10.1186/s40168-023-01564-4 · Cited by 36
“25 were considered statistically significant [30].”
BackgroundThe gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review
Zhang, X., Luo, X., Liang, T. G., Yue, P., Li, M., Liu, K., Zhu, D., Huang, C., Shi, Q., Yang, L., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1286429 · Cited by 45
Wu, J., Huang, H., Wang, L., Gao, M., Meng, S., Zou, S., Feng, Y., Feng, Z., Zhu, Z., Cao, X., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2316575 · Cited by 41
“31,32 We detected and compared the content of butyrate in fecal samples of IBD patients and healthy individuals, confirming that the occurrence of intestinal inflammation does indeed affect the generation of butyrate (Figures 5(b) and 1(a)).”
BackgroundMethodGe, J., Jia, B., Wang, Y., Ma, Y., Sun, X., Dong, J., Jiang, S., & Li, Z. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202402781 · Cited by 41
Che, S., Qin, B., Wu, K., Zhu, M., Hu, H., Peng, C., Wang, Z., Yin, Y., Xia, Y., & Wu, M. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103291 · Cited by 43
“Untargeted metabolic data for SCFA concentrations in human stools (including non-IBD, Crohn ’ s disease (CD), and Ulcerative colitis (UC) patients) were obtained from Project PR000639 in the Metabolomics Workbench (http://www.metabolomicsworkbench.org) [25].”
BackgroundMethodMicrobiota-mediated mechanisms of mucosal immunity across the lifespan
Iliev, I. D., Blander, J. M., Collins, N., Guo, C., Longman, R., Sonnenberg, G. F., Zeng, M. Y., & Artis, D. (2025) · Nature Immunology · doi:10.1038/s41590-025-02281-w · Cited by 66
“A reduction in SCFA-producing bacteria such as F. prausnitzii and Roseburia hominis has been observed in IBD 112–114 that further leads to a reduction in butyrate, propionate and valerate/ isovalerate during IBD dysbiosis 113 .”
Kim, S. H., Lee, W., Kwon, D., Lee, S., Son, S. W., Seo, M., Kim, K., Lee, Y., Kim, S., & Jung, Y. (2020) · Cells · doi:10.3390/cells9020341 · Cited by 41
“immunological, molecular, genetic, microbial, diet, drug use-related, and environmental factors [1,4,5].”
Faecal Metabolomics in Paediatric Inflammatory Bowel Disease: A Systematic Review
Jagt, J. Z., Verburgt, C. M., de Vries, R., de Boer, N. K. H., Benninga, M. A., de Jonge, W. J., Limbergen, J. V., & de Meij, T. G. J. (2022) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjac079 · Cited by 40
Volatile Markers for Cancer in Exhaled Breath—Could They Be the Signature of the Gut Microbiota?
Bhandari, M. P., Poļaka, I., Vangravs, R., Mežmale, L., Veliks, V., Kiršners, A., Mochalski, P., Dias‐Neto, E., & Leja, M. (2023) · Molecules · doi:10.3390/molecules28083488 · Cited by 37
Quantitative electron probe x-ray microanalysis of biological bulk specimens.
Roomans, G. M. (1981) · PubMed · Cited by 37
Lu, W., Xie, Y., Huang, B., Ma, T., Wang, H., Deng, B., Zou, S., Wang, W., Tang, Q., Yang, Z., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc2344 · Cited by 36
Lam, T. J., & Ye, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-22541-1 · Cited by 45
Remodeling of colon plasma cell repertoire within ulcerative colitis patients
Scheid, J. F., Eraslan, B., Hudak, A., Brown, E., Sergio, D., Delorey, T. M., Phillips, D., Lefkovith, A. J., Jess, A. T., Duck, L. W., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20220538 · Cited by 41
Self-citationSo, D., Quigley, E. M. M., & Whelan, K. (2023) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000902 · Cited by 44
Stress, inflammation, microbiome and depression
Medina-Rodriguez, E. M., Cruz, A. A., Abreu, J. C. D., & Beurel, E. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173561 · Cited by 45
Exploring and evaluating microbiome resilience in the gut
Zhou, H., Tang, L., Fenton, K. A., & Song, X. (2025) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiaf046 · Cited by 46
“Multi-omics is an integrated study to elucidate the structur e, c har-acteristics , dynamics , and functions of the microbiome by analyzing the meta genome, tr anscriptome, pr oteome, and metabolome (Lloyd-Price et al. 2019 , Chetty and Blekhman 2024 ).”
InfluentialHuman Microbiome as an Immunoregulatory Axis: Mechanisms, Dysbiosis, and Therapeutic Modulation
Cortes, M., Olate, P., Rodríguez, R., Díaz, R., Martínez, A., Hernández, G., Sepúlveda, N., Paz, E. A., & Quiñones, J. (2025) · Microorganisms · doi:10.3390/microorganisms13092147 · Cited by 54
“Current scientific evidence acknowledges its active participation in the maturation and regulation of the immune system, protection against pathogens, maintenance of immune tolerance, and modulation of inflammatory responses [13].”
Lai, J., Jiang, J., Zhang, P., Xi, C., Wu, L., Gao, X., Zhang, D., Du, Y., Li, Q., Diao, X., et al. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.146 · Cited by 38
Lacroix, V., Cassard, A., Mas, E., & Barreau, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011255 · Cited by 45
Diet and microbiome in the beginning of the sequence of gut inflammation
CEBALLOS, D. S., Hernández-Camba, A., & Ramos, L. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i36.11122 · Cited by 38
Zhang, Q., Xiao, H., Zhan, J.-T., Yuan, B., & Feng, Y. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.01.004 · Cited by 37
Metatranscriptomics captures dynamic shifts in mycorrhizal coordination in boreal forests
Law, S. R., Serrano, A. R., Daguerre, Y., Sundh, J., Schneider, A. N., Stangl, Z. R., Castro, D., Grabherr, M. G., Näsholm, T., Street, N. R., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2118852119 · Cited by 46
“Recent sequencing approaches to measure gene expression within microbial communities (metatranscriptomics) have enabled researchers to complement these taxonomic surveys with real-time functional insights in a range of clinical (5, 6) and ecological (7, 8) settings.”
BackgroundKoppe, L., & Soulage, C. O. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.025 · Cited by 42
Metadata
- Authors
- Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., Andrews, E., Ajami, N. J., Bonham, K. S., Brislawn, C. J., Casero, D., Courtney, H., Gonzalez, A., Graeber, T. G., Hall, A. B., Lake, K., Landers, C. J., Mallick, H., Plichta, D. R., Prasad, M., Rahnavard, G., Sauk, J., Shungin, D., Vázquez-Baeza, Y., White, R. A., IBDMDB Investigators, Bishai, J., Bullock, K., Deik, A., Dennis, C., Kaplan, J. L., Khalili, H., McIver, L. J., Moran, C. J., Nguyen, L., Pierce, K. A., Schwager, R., Sirota-Madi, A., Stevens, B. W., Tan, W., ten Hoeve, J. J., Weingart, G., Wilson, R. G., Yajnik, V., Braun, J., Denson, L. A., Jansson, J. K., Knight, R., Kugathasan, S., McGovern, D. P. B., Petrosino, J. F., Stappenbeck, T. S., Winter, H. S., Clish, C. B., Franzosa, E. A., Vlamakis, H., Xavier, R. J., & Huttenhower, C.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Broad Institute (US)
- Baylor College of Medicine (US)
- Pacific Northwest National Laboratory (US)
- University of California, Los Angeles (US)
- Cincinnati Children's Hospital Medical Center (US)
- Cedars-Sinai Medical Center (US)
- Emory University (US)
- University of California San Diego (US)
- Washington University in St. Louis (US)
- Corresponding author
- Huttenhower, Curtis
- ORCID
- Arze, Cesar
- Ananthakrishnan, Ashwin N.
- Schirmer, Melanie
- Ajami, Nadim J.
- Bonham, Kevin S.
- Brislawn, Colin J.
- Casero, David
- Graeber, Thomas G.
- Hall, A. Brantley
- Mallick, Himel
- Plichta, Damian R.
- Sauk, Jenny
- Shungin, Dmitry
- Bullock, Kevin
- Deik, Amy
- Khalili, Hamed
- McIver, Lauren J.
- Nguyen, Long
- Pierce, Kerry A.
- Yajnik, Vijay
- Knight, Rob
- McGovern, Dermot P. B.
- Winter, Harland S.
- Clish, Clary B.
- Franzosa, Eric A.
- Vlamakis, Hera
- Xavier, Ramnik J.
- Huttenhower, Curtis
- Venue
- Nature
- Published
- 2019-05-29
- Volume
- 569
- Issue
- 7758
- Pages
- 655-662
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6650278
- OpenAlex
- W2947189704
- Cited by
- 3,143
- References
- 101
- Citations by year
- 2026: 500 · 2025: 555 · 2024: 498 · 2023: 402 · 2022: 441 · 2021: 452 · 2020: 247 · 2019: 42
- FWCI
- 98.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- National Science Foundation (1053486, DEAC05–76RL01830, 76RL01830)
- U.S. Department of Energy (DE-AC05–76RL01830, 76RL01830, AC05-76RL01830, DE-AC05?)
- Battelle (AC05-76RL01830, DE- AC05-76RL01830, DE-AC05)
- Leona M. and Harry B. Helmsley Charitable Trust (P01DK046763, U01DK062413)
- Harvard T.H. Chan School of Public Health
- Crohn's and Colitis Foundation (563526)
- Broad Institute
- Vetenskapsrådet (4.1-2016-00416)
- National Institutes of Health (DBI-1053486, UL1TR001881, DE-AC05-76RL01830)
- National Human Genome Research Institute (R01HG005969)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK046763, R24DK110499, U54DK102557, U01DK062413, P30DK078392, P30DK043351, P30DK040561)
- National Institute of Dental and Craniofacial Research (U54DE023798)
- National Center for Advancing Translational Sciences
- Army Research Office (W911NF-11-1-0473, W911NF, W911NF-11)
- Pacific Northwest National Laboratory (DEAC0576RL01830, 76RL01830)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- inflammatory bowel disease, Crohn's disease, ulcerative colitis, gut microbiota, dysbiosis, multi-omics, facultative anaerobes, obligate anaerobes, Clostridia, acylcarnitines, bile acids, short-chain fatty acids, serum antibodies, disease activity, temporal variation, host-microbe interactions
- MeSH terms
- Gastrointestinal Microbiome, Animals, Fungi, Health, Humans, Phylogeny, Species Specificity, Viruses, Inflammatory Bowel Diseases, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.